Moderna Inc
Change company Symbol lookup
Select an option...
MRNA Moderna Inc
LVS Las Vegas Sands Corp
PG Procter & Gamble Co
AMP Ameriprise Financial Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
MRK Merck & Co Inc
HD Home Depot Inc
SQM Sociedad Quimica y Minera de Chile SA
AVGO Broadcom Inc
O Realty Income Corp
Go

Health Care : Biotechnology | Mid Cap Blend
Company profile

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.

Closing Price
$152.74
Day's Change
25.71 (20.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
153.87
Day's Low
141.05
Volume
(Heavy Day)
Volume:
73,203,064

10-day average volume:
30,518,247
73,203,064

Display:

Providers:

UpdateCancel
6 providers

No press release found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.